This case report outlines a very rare case of losartan-induced severe hyponatremia in a 73-year-old type 2 diabetic patient. The patient was initiated with 50 mg daily oral losartan monotherapy for newly diagnosed moderate hypertension. After 3.5 months of taking the drug, he presented to the emergency department in a drowsy state with severe generalized weakness and occasional palpitations. He was a known diabetic for the last 3 years and well controlled by oral metformin alone. On examination, his serum sodium level was found to be 123 meq/L. There were no evidences of any other possible metabolic, infective, organic or other pathologic causes giving rise to that condition, except losartan itself. De-challenge was done and he was treated vigorously resulting in reversal of the diseased state. Naranjo adverse drug reaction probability scale suggested that it was “probable” that oral losartan was responsible for the development of severe hyponatremia in this patient.
[1]
K. Jeong,et al.
Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
,
2013,
Electrolyte & blood pressure : E & BP.
[2]
M. Hayashi.
[Fluid and electrolyte disturbances].
,
2012,
Nihon rinsho. Japanese journal of clinical medicine.
[3]
Fumiatsu Yakushiji,et al.
Losartan potassium/hydrochlorothiazide (Preminent®) and hyponatremia: Case series of 40 patients
,
2011,
Human & experimental toxicology.
[4]
O. Jolobe.
Diuretic-induced hyponatraemia in elderly hypertensive women
,
2003,
Journal of Human Hypertension.
[5]
John Webster,et al.
Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th ed
,
1992
.
[6]
H. Mayan,et al.
Cardiac conduction defects associated with hyponatremia
,
1991,
Clinical cardiology.
[7]
J. Tomaszewski,et al.
Renin and angiotensin.
,
1968,
Lancet.